Cargando…

Impact of Fast SARS-CoV-2 Molecular Point-Of-Care Testing on Patients’ Length of Stay in an Emergency Department

The ID NOW COVID-19 system (IDNOW) is a point-of-care test (POCT) providing results within 15 min. We evaluated the impact of IDNOW use on patient length of stay (LOS) in an emergency department (ED). In the ED of Saint-Louis Hospital, Paris, France, adult patients requiring a rapid diagnosis of SAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Baron, Audrey, Peyrony, Olivier, Salmona, Maud, Mahjoub, Nadia, Ellouze, Sami, Anastassiou, Maud, Delaugerre, Constance, Fontaine, Jean-Paul, Chevret, Sylvie, LeGoff, Jerome, Feghoul, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431206/
https://www.ncbi.nlm.nih.gov/pubmed/35730967
http://dx.doi.org/10.1128/spectrum.00636-22
_version_ 1784779988760788992
author Baron, Audrey
Peyrony, Olivier
Salmona, Maud
Mahjoub, Nadia
Ellouze, Sami
Anastassiou, Maud
Delaugerre, Constance
Fontaine, Jean-Paul
Chevret, Sylvie
LeGoff, Jerome
Feghoul, Linda
author_facet Baron, Audrey
Peyrony, Olivier
Salmona, Maud
Mahjoub, Nadia
Ellouze, Sami
Anastassiou, Maud
Delaugerre, Constance
Fontaine, Jean-Paul
Chevret, Sylvie
LeGoff, Jerome
Feghoul, Linda
author_sort Baron, Audrey
collection PubMed
description The ID NOW COVID-19 system (IDNOW) is a point-of-care test (POCT) providing results within 15 min. We evaluated the impact of IDNOW use on patient length of stay (LOS) in an emergency department (ED). In the ED of Saint-Louis Hospital, Paris, France, adult patients requiring a rapid diagnosis of SARS-CoV-2 were tested with Cepheid Xpert Xpress SARS-CoV-2 or FilmArray respiratory panel RP2 in the virology laboratory between 18 October and 3 November 2020 (period 1) and with IDNOW between 4 November and 30 November 2020 (period 2). A total of 676 patients participated in the study, 337 during period 1 and 339 during period 2. The median LOS in ED was significantly higher in period 1 than in period 2 (276 versus 208 min, P < 0.0001). More patients spent less than 4 h in the ED in period 2 (61.3%) than in period 1 (38.3%) (P < 0.0001). By univariate analysis, factors associated with ED LOS were hypertension, anosmia/ageusia, number of patients per day, and ID NOW implementation in period 2. By multivariate analysis, the period of testing remained significantly associated with ED LOS. Rapid molecular SARS-CoV-2 POCT was associated with a reduced LOS for patients admitted to an ED. IMPORTANCE During COVID-19 pandemic upsurges, emergency departments had to deal with a massive flow of incoming patients. The need for COVID-19 infection status determination before medical ward admission worsened ED overcrowding. The development of molecular point-of-care testing gave new opportunities for getting faster results of SARS-CoV-2 genome detection 24 h a day. In our study, we show, with a multivariate analysis, that the use of the POCT COVID-19 IDNOW reduced the ED length of stay by 1 h. The rate of patients who waited less than 4 h in the ED increased significantly. Our study highlights the benefit of COVID-19 molecular POCT for preventing ED overcrowding and facilitating bed allocation and SARS-CoV-2-infected patient isolation.
format Online
Article
Text
id pubmed-9431206
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-94312062022-09-01 Impact of Fast SARS-CoV-2 Molecular Point-Of-Care Testing on Patients’ Length of Stay in an Emergency Department Baron, Audrey Peyrony, Olivier Salmona, Maud Mahjoub, Nadia Ellouze, Sami Anastassiou, Maud Delaugerre, Constance Fontaine, Jean-Paul Chevret, Sylvie LeGoff, Jerome Feghoul, Linda Microbiol Spectr Research Article The ID NOW COVID-19 system (IDNOW) is a point-of-care test (POCT) providing results within 15 min. We evaluated the impact of IDNOW use on patient length of stay (LOS) in an emergency department (ED). In the ED of Saint-Louis Hospital, Paris, France, adult patients requiring a rapid diagnosis of SARS-CoV-2 were tested with Cepheid Xpert Xpress SARS-CoV-2 or FilmArray respiratory panel RP2 in the virology laboratory between 18 October and 3 November 2020 (period 1) and with IDNOW between 4 November and 30 November 2020 (period 2). A total of 676 patients participated in the study, 337 during period 1 and 339 during period 2. The median LOS in ED was significantly higher in period 1 than in period 2 (276 versus 208 min, P < 0.0001). More patients spent less than 4 h in the ED in period 2 (61.3%) than in period 1 (38.3%) (P < 0.0001). By univariate analysis, factors associated with ED LOS were hypertension, anosmia/ageusia, number of patients per day, and ID NOW implementation in period 2. By multivariate analysis, the period of testing remained significantly associated with ED LOS. Rapid molecular SARS-CoV-2 POCT was associated with a reduced LOS for patients admitted to an ED. IMPORTANCE During COVID-19 pandemic upsurges, emergency departments had to deal with a massive flow of incoming patients. The need for COVID-19 infection status determination before medical ward admission worsened ED overcrowding. The development of molecular point-of-care testing gave new opportunities for getting faster results of SARS-CoV-2 genome detection 24 h a day. In our study, we show, with a multivariate analysis, that the use of the POCT COVID-19 IDNOW reduced the ED length of stay by 1 h. The rate of patients who waited less than 4 h in the ED increased significantly. Our study highlights the benefit of COVID-19 molecular POCT for preventing ED overcrowding and facilitating bed allocation and SARS-CoV-2-infected patient isolation. American Society for Microbiology 2022-06-22 /pmc/articles/PMC9431206/ /pubmed/35730967 http://dx.doi.org/10.1128/spectrum.00636-22 Text en Copyright © 2022 Baron et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Baron, Audrey
Peyrony, Olivier
Salmona, Maud
Mahjoub, Nadia
Ellouze, Sami
Anastassiou, Maud
Delaugerre, Constance
Fontaine, Jean-Paul
Chevret, Sylvie
LeGoff, Jerome
Feghoul, Linda
Impact of Fast SARS-CoV-2 Molecular Point-Of-Care Testing on Patients’ Length of Stay in an Emergency Department
title Impact of Fast SARS-CoV-2 Molecular Point-Of-Care Testing on Patients’ Length of Stay in an Emergency Department
title_full Impact of Fast SARS-CoV-2 Molecular Point-Of-Care Testing on Patients’ Length of Stay in an Emergency Department
title_fullStr Impact of Fast SARS-CoV-2 Molecular Point-Of-Care Testing on Patients’ Length of Stay in an Emergency Department
title_full_unstemmed Impact of Fast SARS-CoV-2 Molecular Point-Of-Care Testing on Patients’ Length of Stay in an Emergency Department
title_short Impact of Fast SARS-CoV-2 Molecular Point-Of-Care Testing on Patients’ Length of Stay in an Emergency Department
title_sort impact of fast sars-cov-2 molecular point-of-care testing on patients’ length of stay in an emergency department
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431206/
https://www.ncbi.nlm.nih.gov/pubmed/35730967
http://dx.doi.org/10.1128/spectrum.00636-22
work_keys_str_mv AT baronaudrey impactoffastsarscov2molecularpointofcaretestingonpatientslengthofstayinanemergencydepartment
AT peyronyolivier impactoffastsarscov2molecularpointofcaretestingonpatientslengthofstayinanemergencydepartment
AT salmonamaud impactoffastsarscov2molecularpointofcaretestingonpatientslengthofstayinanemergencydepartment
AT mahjoubnadia impactoffastsarscov2molecularpointofcaretestingonpatientslengthofstayinanemergencydepartment
AT ellouzesami impactoffastsarscov2molecularpointofcaretestingonpatientslengthofstayinanemergencydepartment
AT anastassioumaud impactoffastsarscov2molecularpointofcaretestingonpatientslengthofstayinanemergencydepartment
AT delaugerreconstance impactoffastsarscov2molecularpointofcaretestingonpatientslengthofstayinanemergencydepartment
AT fontainejeanpaul impactoffastsarscov2molecularpointofcaretestingonpatientslengthofstayinanemergencydepartment
AT chevretsylvie impactoffastsarscov2molecularpointofcaretestingonpatientslengthofstayinanemergencydepartment
AT legoffjerome impactoffastsarscov2molecularpointofcaretestingonpatientslengthofstayinanemergencydepartment
AT feghoullinda impactoffastsarscov2molecularpointofcaretestingonpatientslengthofstayinanemergencydepartment